The Large Volume Parenteral (LVP) Market refers to sterile solutions that are meant to be administered intravenously and have a volume of more than 100ml. The global LVP market is driven by factors such as the increasing prevalence of chronic diseases, rising demand for parenteral nutrition, growing geriatric population, and increasing demand for advanced drug delivery systems.

The market is expected to witness steady growth in the coming years, owing to the increasing use of LVPs in hospitals and healthcare facilities, as well as the rising number of surgeries being performed worldwide. In addition, the development of innovative LVP products and the adoption of advanced manufacturing technologies are also expected to drive market growth.

However, the market is also facing challenges such as the high cost of LVPs, the risk of contamination and infections, and the lack of regulatory standards in some countries. These factors may hinder market growth to some extent.

The LVP market can be segmented based on type, application, end-user, and region. Based on type, the market can be segmented into crystalloids, colloids, and others. Based on application, the market can be segmented into fluid resuscitation, parenteral nutrition, and others. Based on end-user, the market can be segmented into hospitals, clinics, and others. Regionally, the market can be segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/6129

Some of the prominent players profiled in the global LVP market include Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Pfizer Inc., Sandoz International GmbH, Hospira Inc., Otsuka Pharmaceutical Co., Ltd., JW Life Science, and ABBOTT.

  • The fluid balance injection segment is expected to generate the most revenue during the forecast period. This is owing to a high demand for LVP products for fluid balance maintenance in patients suffering from fluid and electrolyte imbalances, dehydration, or hypovolemia. LVP products such as saline solutions and electrolyte solutions are routinely used for fluid replacement treatment in hospitals and other healthcare institutions. Furthermore, the rising prevalence of chronic kidney diseases and renal failure is expected to drive revenue growth in this segment.
  • During the forecast period, the North American market held the greatest share of revenue in the global LVP market, primarily because of the aging population, the growing incidence of chronic diseases, and an upsurge in procedural demand. Nearly six out of every ten individuals in the United States alone suffer from at least one chronic ailment, while four out of ten experience two or more. Additionally, the American Hospital Association (AHA) has reported that hospitals in the U.S. undertake roughly 36 million procedures every year, further fueling the growth of market revenue in this region.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.reportsanddata.com/report-detail/large-volume-parenteral-lvp-market

Here are some key highlights from the report:

  • The global market for LVP or Large Volume Parenteral products witnessed a notable increase in revenue in 2022, with the LVP bags segment holding the largest share of the market. This was primarily due to the exceptional advantages offered by LVP bags, such as their portability, flexibility, and ease of handling. In locations where medical supplies are scarce, LVP bags have become the preferred choice in emergency situations, thanks to their lightweight and convenient storage features. Additionally, LVP bags are safer to handle and transport compared to LVP bottles, as they are less prone to breakage.
  • The fluid balance injection segment is expected to generate the most revenue during the forecast period. This is owing to a high demand for LVP products for fluid balance maintenance in patients suffering from fluid and electrolyte imbalances, dehydration, or hypovolemia. LVP products such as saline solutions and electrolyte solutions are routinely used for fluid replacement treatment in hospitals and other healthcare institutions. Furthermore, the rising prevalence of chronic kidney diseases and renal failure is expected to drive revenue growth in this segment.
  • During the forecast period, the North American market held the greatest share of revenue in the global LVP market, primarily because of the aging population, the growing incidence of chronic diseases, and an upsurge in procedural demand. Nearly six out of every ten individuals in the United States alone suffer from at least one chronic ailment, while four out of ten experience two or more. Additionally, the American Hospital Association (AHA) has reported that hospitals in the U.S. undertake roughly 36 million procedures every year, further fueling the growth of market revenue in this region.
  • During the forecast period, the Europe market is expected to have the fastest-growing revenue rate in the global LVP market. This is related to the increasing prevalence of chronic illnesses and the aging population. Chronic illnesses, according to the World Health Organization (WHO), account for 77% of Europe's sickness burden. Furthermore, the European Society of Cardiology (ESC) reports that Cardiovascular Diseases (CVDs) account for 45% of all fatalities in Europe. LVPs are likely to boost market revenue growth in this area since they are utilized to treat chronic diseases and offer parenteral nutrition treatment.

Custom Requirements can be requested for this Report [Customization Available] @ https://www.reportsanddata.com/request-customization-form/6129

For the purpose of this report, Reports and Data has segmented the global LVP market on the basis of Type Outlook, Application Outlook, and Regional Outlook:

Type Outlook (Revenue, USD Billion; 2022 - 2032)

  • LVP Bags
  • LVP Bottles
  • Others

Application Outlook (Revenue, USD Billion; 2022 - 2032)

  • Fluid Balance Injection
  • Nutrition Injection
  • Others

Regional Outlook (Revenue, USD Billion; 2022-2032)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Sweden
    • BENELUX
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Israel
    • Rest of MEA

Latest Research Reports Published by Reports and Data:

 

Vital Signs Monitoring Market By Product (Blood Pressure Monitors, Pulse Oximeters, Temperature Monitoring Equipment, and Others) By End-Use (Hospitals and Clinics, Home Care Settings, and Others), and By Region Forecast To 2032

Ophthalmic Therapeutics Drugs Market By Drug Type (Anti-Inflammatory Drugs, Anti-Infective Drugs, Anti-Glaucoma Drugs, and Others), By Indication (Dry Eye Syndrome, Glaucoma, Retinal Disorders, and Others), and By Region Forecast to 2032

Personalized Medicine Market by Product Type (Diagnostic Tests, Therapeutics, and Personalized Medical Care), By Application (Oncology, Neurology, Cardiology, Infectious Diseases, and Others), and By Region Forecast to 2032

Wearable Patch Market By Type (Smart Patches, Passive Patches), By Application (Health Monitoring, Drug Delivery, Temperature Monitoring, and Others), and By Region Forecast to 2032

Acromegaly Treatment Market By Type (Drug Therapy, Surgery, Radiation Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region Forecast to 2032

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.


Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report

Read our Press Release @ https://www.reportsanddata.com/press-release/global-large-volume-parenteral-market

Trending Titles Cataract Surgery Device Market | Bone Metastasis Market